Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2025 08:00 ET | Source: Vivos Inc.

Vivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion Plans

Richland, WA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by...
June 28, 2024 10:15 ET | Source: Vivos Inc.

Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials

Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing...
January 03, 2023 09:30 ET | Source: Vivos Inc.

Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment

Richland WA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that they filed a provisional patent application on the system equipment to support precision...
December 02, 2021 09:30 ET | Source: Vivos Inc.

Vivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel™

Richland WA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), on November 30 Vivos Inc met with the Food and Drug Administration to obtain suggestions on improving the current draft of...